Oncology Central

Beyond biologics: is there a role for systemic cytotoxic chemotherapy in neuroendocrine tumors?


Neuroendocrine tumors (NETs) are a group of biologically and clinically heterogeneous neoplasms that have varying degrees of responsiveness to systemic and targeted therapies. With recent advances in therapeutics, a number of biologic therapies have been incorporated into the management of NETs.

To view restricted content, please:

Comments are closed.